[
    [
        {
            "time": "2018-03-01",
            "original_text": "美年大健康面向合格投资者公开发行公司债券并更名",
            "features": {
                "keywords": [
                    "美年大健康",
                    "公司债券",
                    "更名"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "美年大健康面向合格投资者公开发行公司债券并更名",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "[看好评级]医药生物行业周报：关注维生素板块投资机会",
            "features": {
                "keywords": [
                    "医药生物",
                    "维生素",
                    "投资机会"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[看好评级]医药生物行业周报：关注维生素板块投资机会",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "医药股纷纷创新高，是昙花一现还是春天来了？",
            "features": {
                "keywords": [
                    "医药股",
                    "创新高",
                    "昙花一现",
                    "春天"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药股纷纷创新高，是昙花一现还是春天来了？",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "2018年3月医药行业投资策略：追寻确定性、发掘低估值成长股",
            "features": {
                "keywords": [
                    "医药行业",
                    "投资策略",
                    "确定性",
                    "低估值",
                    "成长股"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "2018年3月医药行业投资策略：追寻确定性、发掘低估值成长股",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "晨会聚焦1803013：重点关注中国中药、纺织日化、医药行业、创新药、海外市场、乐普医疗",
            "features": {
                "keywords": [
                    "中国中药",
                    "纺织日化",
                    "医药行业",
                    "创新药",
                    "海外市场",
                    "乐普医疗"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "创新药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "晨会聚焦1803013：重点关注中国中药、纺织日化、医药行业、创新药、海外市场、乐普医疗",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "马云再出手！爱康国宾私有化之路尘埃落定，阿里将如何打造医疗生态帝国？",
            "features": {
                "keywords": [
                    "马云",
                    "爱康国宾",
                    "私有化",
                    "阿里",
                    "医疗生态"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "马云再出手！爱康国宾私有化之路尘埃落定，阿里将如何打造医疗生态帝国？",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "【晨会聚焦】创新药进入兑现年；关注维生素涨价相关标的",
            "features": {
                "keywords": [
                    "创新药",
                    "兑现年",
                    "维生素",
                    "涨价"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "创新药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【晨会聚焦】创新药进入兑现年；关注维生素涨价相关标的",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "【医药*全铭团队】坚定看好医药行业的向上拐点机会，建议增配医药",
            "features": {
                "keywords": [
                    "医药",
                    "向上拐点",
                    "增配"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【医药*全铭团队】坚定看好医药行业的向上拐点机会，建议增配医药",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "医药周报2018年第9期:关注度提升,把握结构性机会",
            "features": {
                "keywords": [
                    "医药周报",
                    "关注度提升",
                    "结构性机会"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药周报2018年第9期:关注度提升,把握结构性机会",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "医药行业周报:看好创新药、疫苗及消费升级机会,推荐恒瑞医药、安科生物、片仔癀等",
            "features": {
                "keywords": [
                    "医药行业",
                    "创新药",
                    "疫苗",
                    "消费升级",
                    "恒瑞医药",
                    "安科生物",
                    "片仔癀"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "创新药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业周报:看好创新药、疫苗及消费升级机会,推荐恒瑞医药、安科生物、片仔癀等",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        }
    ]
]